Reviews, Commentaries, Profiles and Hypothesis Articles - FREE TO ALL

Full text files of all Review Articles, Commentaries, Profiles and Hypothesis Articles published in Society for Endocrinology journals (Endocrine-Related Cancer, Journal of Molecular Endocrinology and Journal of Endocrinology) are freely available to all. Sign-up for Table of Contents alerts to receive notification of new articles.

Details are listed below.

FREE ARCHIVE 2016

  • REVIEW: Samantha Peiling Yang and Joanne Ngeow
  • Familial non-medullary thyroid cancer: unraveling the genetic maze
  • Endocrine-Related Cancer 23 R577–R595 (December 2016)
  • REVIEW: Caroline Wilson, Hannah Brown, and Ingunn Holen
  • The endocrine influence on the bone microenvironment in early breast cancer
  • Endocrine-Related Cancer 23 R567–R576 (December 2016)
  • REVIEW: Kjell Öberg and Steven W J Lamberts
  • Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future
  • Endocrine-Related Cancer 23 R551–R566 (December 2016)
  • THEMATIC REVIEW: John W Cassidy, Ankita S Batra, Wendy Greenwood, and Alejandra Bruna
  • Patient-derived tumour xenografts for breast cancer drug discovery
  • Endocrine-Related Cancer 23 T259–T270 (December 2016)
  • THEMATIC REVIEW: Patricia V Elizalde, Rosalía I Cordo Russo, Maria F Chervo, and Roxana Schillaci
  • ErbB-2 nuclear function in breast cancer growth, metastasis and resistance to therapy
  • Endocrine-Related Cancer 23 T243–T257 (December 2016)
  • THEMATIC REVIEW: Elgene Lim, Gerard Tarulli, Neil Portman, Theresa E Hickey, Wayne D Tilley, and Carlo Palmieri
  • Pushing estrogen receptor around in breast cancer
  • Endocrine-Related Cancer 23 T227–T241 (December 2016)
  • THEMATIC REVIEW: Muhammed H Rahaman, Malika Kumarasiri, Laychiluh B Mekonnen, Mingfeng Yu, Sarah Diab, Hugo Albrecht, Robert W Milne, and Shudong Wang
  • Targeting CDK9: a promising therapeutic opportunity in prostate cancer
  • Endocrine-Related Cancer 23 T211–T226 (December 2016)
  • THEMATIC REVIEW: Subing Cao, Yang Zhan, and Yan Dong
  • Emerging data on androgen receptor splice variants in prostate cancer
  • Endocrine-Related Cancer 23 T199–T210 (December 2016)
  • THEMATIC REVIEW: Isabel Coutinho, Tanya K Day, Wayne D Tilley, and Luke A Selth
  • Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence
  • Endocrine-Related Cancer 23 T179–T197 (December 2016)
  • EDITORIAL: Wayne D Tilley
  • Novel twists in hormone-mediated carcinogenesis
  • Endocrine-Related Cancer 23 E9–E12 (December 2016)
  • REVIEW: S P Sivarajasingam, N Imami, and M R Johnson
  • Myometrial cytokines and their role in the onset of labour
  • Journal of Endocrinology 231 R101–R119 (December 2016)
  • REVIEW: Liping Luo and Meilian Liu
  • Adipose tissue in control of metabolism
  • Journal of Endocrinology 231 R77–R99 (December 2016)
  • REVIEW: Aleksandra M Ochnik and Robert C Baxter
  • Combination therapy approaches to target insulin-like growth factor receptor signaling in breast cancer
  • Endocrine-Related Cancer 23 R527–R550 (November 2016)
  • REVIEW: Iman Azimi and Gregory R Monteith
  • Plasma membrane ion channels and epithelial to mesenchymal transition in cancer cells
  • Endocrine-Related Cancer 23 R517–R525 (November 2016)
  • REVIEW: Vincenzo Marotta, Concetta Sciammarella, Annamaria Colao, and Antongiulio Faggiano
  • Application of molecular biology of differentiated thyroid cancer for clinical prognostication
  • Endocrine-Related Cancer 23 R499–R515 (November 2016)
  • COMMENTARY: Ioulia Chatzistamou and Hippokratis Kiaris
  • Modeling estrogen receptor-positive breast cancers in mice: is it the best we can do?
  • Endocrine-Related Cancer 23 C9–C12 (November 2016)
  • WOMEN IN CANCER THEMATIC REVIEW: Thomas J Sweet and Angela H Ting
  • Diverse functions of DNA methylation: implications for prostate cancer and beyond
  • Endocrine-Related Cancer 23 T169–T178 (November 2016)
  • WOMEN IN CANCER PROFILE: Angela H Ting
  • Dude, where’s my band?
  • Endocrine-Related Cancer 23 P33–P35 (November 2016)
  • WOMEN IN CANCER THEMATIC REVIEW: C Ricciardelli, N A Lokman, M P Ween, and M K Oehler
  • Ovarian cancer–peritoneal cell interactions promote extracellular matrix processing
  • Endocrine-Related Cancer 23 T155–T168 (November 2016)
  • WOMEN IN CANCER PROFILE: Carmela Ricciardelli
  • My pathway to understanding the role of the tumour microenvironment in cancer progression
  • Endocrine-Related Cancer 23 P27–P31 (November 2016)
  • WOMEN IN CANCER THEMATIC REVIEW: Marianne E Pavel and Christine Sers
  • Systemic therapies in neuroendocrine tumors and novel approaches toward personalized medicine
  • Endocrine-Related Cancer 23 T135–T154 (November 2016)
  • WOMEN IN CANCER PROFILE: Marianne E Pavel
  • Neuroendocrine tumors: moving from the land of small tumors to an expanding universe
  • Endocrine-Related Cancer 23 P23–P26 (November 2016)
  • WOMEN IN CANCER THEMATIC REVIEW: Zsofia Kiss and Paramita M Ghosh
  • Circadian rhythmicity and the influence of ‘clock’ genes on prostate cancer
  • Endocrine-Related Cancer 23 T123–T134 (November 2016)
  • WOMEN IN CANCER PROFILE: Paramita M Ghosh
  • From physics to cancer biology and everywhere in between
  • Endocrine-Related Cancer 23 P15–P21 (November 2016)
  • WOMEN IN CANCER THEMATIC REVIEW: Hannah Nieto and Kristien Boelaert
  • Thyroid-stimulating hormone in thyroid cancer: does it matter?
  • Endocrine-Related Cancer 23 T109–T121 (November 2016)
  • WOMEN IN CANCER PROFILE: Kristien Boelaert
  • From bedside to bench and back: my journey in thyroid disease
  • Endocrine-Related Cancer 23 P9–P13 (November 2016)
  • WOMEN IN CANCER THEMATIC REVIEW: Damien A Leach, Sue M Powell, and Charlotte L Bevan
  • New roles for nuclear receptors in prostate cancer
  • Endocrine-Related Cancer 23 T85–T108 (November 2016)
  • WOMEN IN CANCER PROFILE: Charlotte L Bevan
  • A gender agenda?
  • Endocrine-Related Cancer 23 P5–P8 (November 2016)
  • EDITORIAL: Deborah J Marsh and Charis Eng
  • Lessons learnt from outstanding mid-career women in endocrine cancer research
  • Endocrine-Related Cancer 23 E5–E5 (November 2016)
  • REVIEW: Carrie S Shemanko
  • Prolactin receptor in breast cancer: marker for metastatic risk
  • Journal of Molecular Endocrinology 57 R153–R165 (November 2016)
  • REVIEW: Lichun Zhou, Baohua Ma, and Xiuzhen Han
  • The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy
  • Journal of Molecular Endocrinology 57 R143–R152 (November 2016)
  • REVIEW: Che-Pei Kung and Maureen E Murphy
  • The role of the p53 tumor suppressor in metabolism and diabetes
  • Journal of Endocrinology 231 R61–R75 (November 2016)
  • REVIEW: Baiba Steinbrekera and Robert Roghair
  • Modeling the impact of growth and leptin deficits on the neuronal regulation of blood pressure
  • Journal of Endocrinology 231 R47–R60 (November 2016)
  • REVIEW: Elisabetta Pietri, Vincenza Conteduca, Daniele Andreis, Ilaria Massa, Elisabetta Melegari, Samanta Sarti, Lorenzo Cecconetto, Alessio Schirone, Sara Bravaccini, Patrizia Serra, Anna Fedeli, Roberta Maltoni, Dino Amadori, Ugo De Giorgi, and Andrea Rocca
  • Androgen receptor signaling pathways as a target for breast cancer treatment
  • Endocrine-Related Cancer 23 R485–R498 (October 2016)
  • REVIEW: S Latteyer, V Tiedje, B Schilling, and D Führer
  • Perspectives for immunotherapy in endocrine cancer
  • Endocrine-Related Cancer 23 R469–R484 (October 2016)
  • REVIEW: Ju-Yeon Moon, Man Ho Choi, and Jayoung Kim
  • Metabolic profiling of cholesterol and sex steroid hormones to monitor urological diseases
  • Endocrine-Related Cancer 23 R455–R467 (October 2016)
  • REVIEW: Ravi Kumar Dutta, Peter Söderkvist, and Oliver Gimm
  • Genetics of primary hyperaldosteronism
  • Endocrine-Related Cancer 23 R437–R454 (October 2016)
  • THEMATIC REVIEW: Roger L Milne and Antonis C Antoniou
  • Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers
  • Endocrine-Related Cancer 23 T69–T84 (October 2016)
  • THEMATIC REVIEW: Louis de Mestier, Jean-Baptiste Danset, Cindy Neuzillet, Vinciane Rebours, Jérôme Cros, Nadem Soufir, and Pascal Hammel
  • Pancreatic ductal adenocarcinoma in BRCA2 mutation carriers
  • Endocrine-Related Cancer 23 T57–T67 (October 2016)
  • THEMATIC REVIEW: Kiranjit K Dhillon, Ilirjana Bajrami, Toshiyasu Taniguchi, and Christopher J Lord
  • Synthetic lethality: the road to novel therapies for breast cancer
  • Endocrine-Related Cancer 23 T39–T55 (October 2016)
  • THEMATIC REVIEW: Yoko Katsuki and Minoru Takata
  • Defects in homologous recombination repair behind the human diseases: FA and HBOC
  • Endocrine-Related Cancer 23 T19–T37 (October 2016)
  • THEMATIC REVIEW: Amélie Fradet-Turcotte, Justine Sitz, Damien Grapton, and Alexandre Orthwein
  • BRCA2 functions: from DNA repair to replication fork stabilization
  • Endocrine-Related Cancer 23 T1–T17 (October 2016)
  • EDITORIAL: William D Foulkes and Kokichi Sugano
  • BRCA2: a grown-up cancer susceptibility gene
  • Endocrine-Related Cancer 23 E1–E3 (October 2016)
  • REVIEW: Fadil M Hannan, Valerie N Babinsky, and Rajesh V Thakker
  • Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis
  • Journal of Molecular Endocrinology 57 R127–R142 (October 2016)
  • FOCUSED REVIEW: Jessica Sabourin and Florent Allagnat
  • Store-operated Ca2+ entry: a key component of the insulin secretion machinery
  • Journal of Molecular Endocrinology 57 F35–F39 (October 2016)
  • REVIEW: Bernard Freudenthal, John Logan, Sanger Institute Mouse Pipelines, Peter I Croucher, Graham R Williams, and J H Duncan Bassett
  • Rapid phenotyping of knockout mice to identify genetic determinants of bone strength
  • Journal of Endocrinology 231 R31–R46 (October 2016)
  • REVIEW: Vimal Selvaraj and Lan N Tu
  • Current status and future perspectives: TSPO in steroid neuroendocrinology
  • Journal of Endocrinology 231 R1–R30 (October 2016)
  • REVIEW: Georgios K Dimitriadis, Martin O Weickert, Harpal S Randeva, Gregory Kaltsas, and Ashley Grossman
  • Medical management of secretory syndromes related to gastroenteropancreatic neuroendocrine tumours
  • Endocrine-Related Cancer 23 R423–R436 (September 2016)
  • REVIEW: Carlos Cardenas, Ayesha B Alvero, Bo Seong Yun, and Gil Mor
  • Redefining the origin and evolution of ovarian cancer: a hormonal connection
  • Endocrine-Related Cancer 23 R411–R422 (September 2016)
  • REVIEW: Sakine Sever, Donna L White, and José M Garcia
  • Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review
  • Endocrine-Related Cancer 23 R393–R409 (September 2016)
  • REVIEW: Laura A Baker, Holly Holliday, and Alexander Swarbrick
  • ID4 controls luminal lineage commitment in normal mammary epithelium and inhibits BRCA1 function in basal-like breast cancer
  • Endocrine-Related Cancer 23 R381–R392 (September 2016)
  • REVIEW: Arthur Varoquaux, Electron Kebebew, Fréderic Sebag, Katherine Wolf, Jean-François Henry, Karel Pacak, and David Taïeb
  • Endocrine tumors associated with the vagus nerve
  • Endocrine-Related Cancer 23 R371–R379 (September 2016)
  • REVIEW: Urszula T Iwaniec and Russell T Turner
  • Influence of body weight on bone mass, architecture and turnover
  • Journal of Endocrinology 230 R115–R130 (September 2016)
  • REVIEW: Paige V Bauer and Frank A Duca
  • Targeting the gastrointestinal tract to treat type 2 diabetes
  • Journal of Endocrinology 230 R95–R113 (September 2016)
  • FOCUSED REVIEW: Menghong Yan and Qiwei Zhai
  • Sperm tsRNAs and acquired metabolic disorders
  • Journal of Endocrinology 230 F13–F18 (September 2016)
  • REVIEW: Andrea Perra, Michelina Plateroti, and Amedeo Columbano
  • T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair
  • Endocrine-Related Cancer 23 R353–R369 (August 2016)
  • REVIEW: Conleth G Murphy and Maura N Dickler
  • Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies
  • Endocrine-Related Cancer 23 R337–R352 (August 2016)
  • COMMENTARY: Lisa Bodei, Irvin M Modlin, Markus Luster, Flavio Forrer, Marta Cremonesi, Rodney J Hicks, Samer Ezziddin, Mark Kidd, and Arturo Chiti
  • Myeloid neoplasms after chemotherapy and PRRT: myth and reality
  • Endocrine-Related Cancer 23 C1–C7 (August 2016)
  • REVIEW: Silvia Giatti, Roberto Cosimo Melcangi, and Marzia Pesaresi
  • The other side of progestins: effects in the brain
  • Journal of Molecular Endocrinology 57 R109–R126 (August 2016)
  • REVIEW: Haihua Yang and Linghai Yang
  • Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
  • Journal of Molecular Endocrinology 57 R93–R108 (August 2016)
  • REVIEW: Suzy Markossian and Frédéric Flamant
  • CRISPR/Cas9: a breakthrough in generating mouse models for endocrinologists
  • Journal of Molecular Endocrinology 57 R81–R92 (August 2016)
  • FOCUSED REVIEW: Ayse Elif Erson-Bensan
  • Alternative polyadenylation and RNA-binding proteins
  • Journal of Molecular Endocrinology 57 F29–F34 (August 2016)
  • FOCUSED REVIEW: Rosalia C M Simmen and Angela S Kelley
  • Reversal of fortune: estrogen receptor-β in endometriosis
  • Journal of Molecular Endocrinology 57 F23–F27 (August 2016)
  • REVIEW: Yolanda Diz-Chaves, Manuel Gil-Lozano, Laura Toba, Juan Fandiño, Hugo Ogando, Lucas C González-Matías, and Federico Mallo
  • Stressing diabetes? The hidden links between insulinotropic peptides and the HPA axis
  • Journal of Endocrinology 230 R77–R94 (August 2016)
  • REVIEW: Michael C Velarde and Ramkumar Menon
  • Positive and negative effects of cellular senescence during female reproductive aging and pregnancy
  • Journal of Endocrinology 230 R59–R76 (August 2016)
  • REVIEW: Jaroslav Kuneš, Veronika Pražienková, Andrea Popelová, Barbora Mikulášková, Jana Zemenová, and Lenka Maletínská
  • Prolactin-releasing peptide: a new tool for obesity treatment
  • Journal of Endocrinology 230 R51–R58 (August 2016)
  • REVIEW: Kiyoshi Ito, Yasuhiro Miki, Takashi Suzuki, Keely May McNamara, and Hironobu Sasano
  • In situ androgen and estrogen biosynthesis in endometrial cancer: focus on androgen actions and intratumoral production
  • Endocrine-Related Cancer 23 R323–R335 (July 2016)
  • REVIEW: Gunnar Kleinau, Anne Müller, and Heike Biebermann
  • Oligomerization of GPCRs involved in endocrine regulati
  • Journal of Molecular Endocrinology 57 R59–R80 (July 2016)
  • REVIEW: Christopher E Wall, Ruth T Yu, Anne R Atkins, Michael Downes, and Ronald M Evans
  • Nuclear receptors and AMPK: can exercise mimetics cure diabetes?
  • Journal of Molecular Endocrinology 57 R49–R58 (July 2016)
  • REVIEW: Douglas A Gibson, Ioannis Simitsidellis, and Philippa T K Saunders
  • Regulation of androgen action during establishment of pregnancy
  • Journal of Molecular Endocrinology 57 R35–R47 (July 2016)
  • REVIEW: Hong Zhao, Ling Zhou, Anna Junjie Shangguan, and Serdar E Bulun
  • Aromatase expression and regulation in breast and endometrial cancer
  • Journal of Molecular Endocrinology 57 R19–R33 (July 2016)
  • REVIEW: Kira Meyerovich, Fernanda Ortis, Florent Allagnat, and Alessandra K Cardozo
  • Endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation
  • Journal of Molecular Endocrinology 57 R1–R17 (July 2016)
  • FOCUSED REVIEW: Aurelie Nguyen Dinh Cat, Malou Friederich-Persson, Anna White, and Rhian M Touyz
  • Adipocytes, aldosterone and obesity-related hypertension
  • Journal of Molecular Endocrinology 57 F7–F21 (July 2016)
  • FOCUSED REVIEW: Ylenia Perone and Luca Magnani
  • Going off the grid: ERα breast cancer beyond estradiol
  • Journal of Molecular Endocrinology 57 F1–F5 (July 2016)
  • REVIEW: Jennifer A Evans
  • Collective timekeeping among cells of the master circadian clock
  • Journal of Endocrinology 230 R27–R49 (July 2016)
  • REVIEW: Geoffrey L Hammond
  • Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action
  • Journal of Endocrinology 230 R13–R25 (July 2016)
  • REVIEW: Anthony H Tsang, Mariana Astiz, Maureen Friedrichs, and Henrik Oster
  • Endocrine regulation of circadian physiology
  • Journal of Endocrinology 230 R1–R11 (July 2016)
  • FOCUSED REVIEW: Ding Xie and Wendy B Bollag
  • Obesity, hypertension and aldosterone: is leptin the link?
  • Journal of Endocrinology 230 F7–F11 (July 2016)
  • FOCUSED REVIEW: Norbert Gleicher, Vitaly A Kushnir, David F Albertini, and David H Barad
  • Improvements in IVF in women of advanced age
  • Journal of Endocrinology 230 F1–F6 (July 2016)
  • REVIEW: M Wijnen, M M van den Heuvel-Eibrink, M Medici, R P Peeters, A J van der Lely, and S J C M M Neggers
  • Risk factors for subsequent endocrine-related cancer in childhood cancer survivors
  • Endocrine-Related Cancer 23 R299–R321 (June 2016)
  • REVIEW: Christine Spitzweg, John C Morris, and Keith C Bible
  • New drugs for medullary thyroid cancer: new promises?
  • Endocrine-Related Cancer 23 R287–R297 (June 2016)
  • REVIEW: Diana Lim and Joanne Ngeow
  • Evaluation of the methods to identify patients who may benefit from PARP inhibitor use
  • Endocrine-Related Cancer 23 R267–R285 (June 2016)
  • REVIEW: Habibur P Rahman, Johannes Hofland, and Paul A Foster
  • In touch with your feminine side: how oestrogen metabolism impacts prostate cancer
  • Endocrine-Related Cancer 23 R249–R266 (June 2016)
  • REVIEW: Yulong Li and William F Simonds
  • Endocrine neoplasms in familial syndromes of hyperparathyroidism
  • Endocrine-Related Cancer 23 R229–R247 (June 2016)
  • REVIEW: Eduardo Esteban-Zubero, Francisco Agustín García-Gil, Laura López-Pingarrón, Moisés Alejandro Alatorre-Jiménez, Pablo Iñigo-Gil, Dun-Xian Tan, José Joaquín García, and Russel J Reiter
  • Potential benefits of melatonin in organ transplantation: a review
  • Journal of Endocrinology 229 R129–R146 (June 2016)
  • REVIEW: Taeko Nishiwaki-Ohkawa and Takashi Yoshimura
  • Molecular basis for regulating seasonal reproduction in vertebrates
  • Journal of Endocrinology 229 R117–R127 (June 2016)
  • REVIEW: Haijiang Wu, Xinna Deng, Yonghong Shi, Ye Su, Jinying Wei, and Huijun Duan
  • PGC-1α, glucose metabolism and type 2 diabetes mellitus
  • Journal of Endocrinology 229 R99–R115 (June 2016)
  • REVIEW: Sophie A Clarke and Waljit S Dhillo
  • Kisspeptin across the human lifespan:evidence from animal studies and beyond
  • Journal of Endocrinology 229 R83–R98 (June 2016)
  • REVIEW: Lisa M Butler, Margaret M Centenera, and Johannes V Swinnen
  • Androgen control of lipid metabolism in prostate cancer: novel insights and future applications
  • Endocrine-Related Cancer 23 R219–R227 (May 2016)
  • PROFILE: Nancy E Davidson
  • Serendipity and purpose
  • Endocrine-Related Cancer 23 P1–P3 (May 2016)
  • THEMATIC REVIEW: Erica J P Anderson, Isin Çakir, Sheridan J Carrington, Roger D Cone, Masoud Ghamari-Langroudi, Taneisha Gillyard, Luis E Gimenez, and Michael J Litt
  • 60 YEARS OF POMC: Regulation of feeding and energy homeostasis by α-MSH
  • Journal of Molecular Endocrinology 56 T157–T174 (May 2016)
  • THEMATIC REVIEW: Nicole Gallo-Payet
  • 60 YEARS OF POMC: Adrenal and extra-adrenal functions of ACTH
  • Journal of Molecular Endocrinology 56 T135–T156 (May 2016)
  • THEMATIC REVIEW: Robert M Dores, Liang Liang, Perry Davis, Alexa L Thomas, and Bogdana Petko
  • 60 YEARS OF POMC: Melanocortin receptors: evolution of ligand selectivity for melanocortin peptides
  • Journal of Molecular Endocrinology 56 T119–T133 (May 2016)
  • THEMATIC REVIEW: Sandra Navarro, Lucia Soletto, Sara Puchol, Josep Rotllant, Jose Luis Soengas, and Jose Miguel Cerdá-Reverter
  • 60 YEARS OF POMC: POMC: an evolutionary perspective
  • Journal of Molecular Endocrinology 56 T113–T118 (May 2016)
  • THEMATIC REVIEW: Jacques Drouin
  • 60 YEARS OF POMC: Transcriptional and epigenetic regulation of POMC gene expression
  • Journal of Molecular Endocrinology 56 T99–T112 (May 2016)
  • THEMATIC REVIEW: Niamh X Cawley, Zhaojin Li, and Y Peng Loh
  • 60 YEARS OF POMC: Biosynthesis, trafficking, and secretion of pro-opiomelanocortin-derived peptides
  • Journal of Molecular Endocrinology 56 T77–T97 (May 2016)
  • THEMATIC REVIEW: Dhivya Kumar, Richard E Mains, and Betty A Eipper
  • 60 YEARS OF POMC: From POMC and α-MSH to PAM, molecular oxygen, copper, and vitamin C
  • Journal of Molecular Endocrinology 56 T63–T76 (May 2016)
  • THEMATIC REVIEW: Michel Chrétien and Majambu Mbikay
  • 60 YEARS OF POMC: From the prohormone theory to pro-opiomelanocortin and to proprotein convertases (PCSK1 to PCSK9)
  • Journal of Molecular Endocrinology 56 T49–T62 (May 2016)
  • THEMATIC REVIEW: Andrew B Bicknell
  • 60 YEARS OF POMC: N-terminal POMC peptides and adrenal growth
  • Journal of Molecular Endocrinology 56 T39–T48 (May 2016)
  • THEMATIC REVIEW: Adrian J L Clark
  • 60 YEARS OF POMC: The proopiomelanocortin gene: discovery, deletion and disease
  • Journal of Molecular Endocrinology 56 T27–T37 (May 2016)
  • THEMATIC REVIEW: D G Smyth
  • 60 YEARS OF POMC: Lipotropin and beta-endorphin: a perspective
  • Journal of Molecular Endocrinology 56 T13–T25 (May 2016)
  • THEMATIC REVIEW: Philip Lowry
  • 60 YEARS OF POMC: Purification and biological characterisation of melanotrophins and corticotrophins
  • Journal of Molecular Endocrinology 56 T1–T12 (May 2016)
  • EDITORIAL: Adrian J L Clark and Philip Lowry
  • 60 YEARS OF POMC: POMC: the consummate peptide hormone precursor
  • Journal of Molecular Endocrinology 56 E1–E2 (May 2016)
  • REVIEW: Mark E Cleasby, Pauline M Jamieson, and Philip J Atherton
  • Insulin resistance and sarcopenia: mechanistic links between common co-morbidities
  • Journal of Endocrinology 229 R67–R81 (May 2016)
  • REVIEW: Antonella Amato, Sara Baldassano, and Flavia Mulè
  • GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity
  • Journal of Endocrinology 229 R57–R66 (May 2016)
  • REVIEW: Koen D Flach and Wilbert Zwart
  • The first decade of estrogen receptor cistromics in breast cancer
  • Journal of Endocrinology 229 R43–R56 (May 2016)
  • REVIEW: Jamie L Van Etten and Scott M Dehm
  • Clonal origin and spread of metastatic prostate cancer
  • Endocrine-Related Cancer 23 R207–R217 (April 2016)
  • REVIEW: David Viola, Laura Valerio, Eleonora Molinaro, Laura Agate, Valeria Bottici, Agnese Biagini, Loredana Lorusso, Virginia Cappagli, Letizia Pieruzzi, Carlotta Giani, Elena Sabini, Paolo Passannati, Luciana Puleo, Antonio Matrone, Benedetta Pontillo-Contillo, Valentina Battaglia, Salvatore Mazzeo, Paolo Vitti, and Rossella Elisei
  • Treatment of advanced thyroid cancer with targeted therapies: ten years of experience
  • Endocrine-Related Cancer 23 R185–R205 (April 2016)
  • REVIEW: Russell A Prough, Barbara J Clark, and Carolyn M Klinge
  • Novel mechanisms for DHEA action
  • Journal of Molecular Endocrinology 56 R139–R155 (April 2016)
  • REVIEW: I Robertshaw, F Bian, and S K Das
  • Mechanisms of uterine estrogen signaling during early pregnancy in mice: an update
  • Journal of Molecular Endocrinology 56 R127–R138 (April 2016)
  • REVIEW: Philip A Gruppuso and Jennifer A Sanders
  • Regulation of liver development: implications for liver biology across the lifespan
  • Journal of Molecular Endocrinology 56 R115–R125 (April 2016)
  • REVIEW: Katherine A Leehy, Tarah M Regan Anderson, Andrea R Daniel, Carol A Lange, and Julie H Ostrander
  • Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer
  • Journal of Molecular Endocrinology 56 R99–R114 (April 2016)
  • REVIEW: Inna Astapova
  • Role of co-regulators in metabolic and transcriptional actions of thyroid hormone
  • Journal of Molecular Endocrinology 56 R73–R97 (April 2016)
  • REVIEW: Wendy B Bollag
  • Role of phospholipases in adrenal steroidogenesis
  • Journal of Endocrinology 229 R29–R41 (April 2016)
  • REVIEW: Kerryn M Taylor, David W Ray, and Paula Sommer
  • Glucocorticoid receptors in lung cancer: new perspectives
  • Journal of Endocrinology 229 R17–R28 (April 2016)
  • REVIEW: Chiung-Kuei Huang, Soo Ok Lee, Eugene Chang, Haiyan Pang, and Chawnshang Chang
  • Androgen receptor (AR) in cardiovascular diseases
  • Journal of Endocrinology 229 R1–R16 (April 2016)
  • REVIEW: Maria Chiara Zatelli, Giuseppe Fanciulli, Pasqualino Malandrino, Valeria Ramundo, Antongiulio Faggiano, Annamaria Colao, and on behalf of NIKE Group
  • Predictive factors of response to mTOR inhibitors in neuroendocrine tumours
  • Endocrine-Related Cancer 23 R173–R183 (March 2016)
  • REVIEW: Kristina Warton, Kate L Mahon, and Goli Samimi
  • Methylated circulating tumor DNA in blood: power in cancer prognosis and response
  • Endocrine-Related Cancer 23 R157–R171 (March 2016)
  • REVIEW: Rengyun Liu and Mingzhao Xing
  • TERT promoter mutations in thyroid cancer
  • Endocrine-Related Cancer 23 R143–R155 (March 2016)
  • REVIEW: Hongying An and Ling He
  • Current understanding of metformin effect on the control of hyperglycemia in diabetes
  • Journal of Endocrinology 228 R97–R106 (March 2016)
  • REVIEW: Libor Vítek and Martin Haluzík
  • The role of bile acids in metabolic regulation
  • Journal of Endocrinology 228 R85–R96 (March 2016)
  • REVIEW: M Victoria Recouvreux, M Andrea Camilletti, Daniel B Rifkin, and Graciela Díaz-Torga
  • The pituitary TGFβ1 system as a novel target for the treatment of resistant prolactinomas
  • Journal of Endocrinology 228 R73–R83 (March 2016)
  • REVIEW: Carole Guerin, David Taieb, Giorgio Treglia, Thierry Brue, André Lacroix, Frederic Sebag, and Frederic Castinetti
  • Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism?
  • Endocrine-Related Cancer 23 R131–R142 (February 2016)
  • REVIEW: M Bullock
  • FOXO factors and breast cancer: outfoxing endocrine resistance
  • Endocrine-Related Cancer 23 R113–R130 (February 2016)
  • REVIEW: Annu Makker and Madhu Mati Goel
  • Tumor progression, metastasis, and modulators of epithelial–mesenchymal transition in endometrioid endometrial carcinoma: an update
  • Endocrine-Related Cancer 23 R85–R111 (February 2016)
  • REVIEW: Ana Albero, Juliana Ester Lopéz, Alberto Torres, Luis de la Cruz, and Tomas Martín
  • Effectiveness of chemotherapy in advanced differentiated thyroid cancer: a systematic review
  • Endocrine-Related Cancer 23 R71–R84 (February 2016)
  • REVIEW: Sylvia C Hewitt, Wipawee Winuthayanon, and Kenneth S Korach
  • What's new in estrogen receptor action in the female reproductive tract
  • Journal of Molecular Endocrinology 56 R55–R71 (February 2016)
  • REVIEW: Sumaira Z Hasnain, Johannes B Prins, and Michael A McGuckin
  • Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes
  • Journal of Molecular Endocrinology 56 R33–R54 (February 2016)
  • REVIEW: Charlotte Lawson, Jose M Vicencio, Derek M Yellon, and Sean M Davidson
  • Microvesicles and exosomes: new players in metabolic and cardiovascular disease
  • Journal of Endocrinology 228 R57–R71 (February 2016)
  • REVIEW: Almas R Juma, Pauliina E Damdimopoulou, Sylvia V H Grommen, Wim J M Van de Ven, and Bert De Groef
  • Emerging role of PLAG1 as a regulator of growth and reproduction
  • Journal of Endocrinology 228 R45–R56 (February 2016)
  • REVIEW: Christopher A Price
  • Mechanisms of fibroblast growth factor signaling in the ovarian follicle
  • Journal of Endocrinology 228 R31–R43 (February 2016)
  • REVIEW: S G Creemers, L J Hofland, E Korpershoek, G J H Franssen, F J van Kemenade, W W de Herder, and R A Feelders
  • Future directions in the diagnosis and medical treatment of adrenocortical carcinoma
  • Endocrine-Related Cancer 23 R43–R69 (January 2016)
  • REVIEW: Krystallenia I Alexandraki, Gregory A Kaltsas, Simona Grozinsky-Glasberg, Eleftherios Chatzellis, and Ashley B Grossman
  • Appendiceal neuroendocrine neoplasms: diagnosis and management
  • Endocrine-Related Cancer 23 R27–R41 (January 2016)
  • REVIEW: Casey de Rooy, Mathis Grossmann, Jeffrey D Zajac, and Ada S Cheung
  • Targeting muscle signaling pathways to minimize adverse effects of androgen deprivation
  • Endocrine-Related Cancer 23 R15–R26 (January 2016)
  • REVIEW: Stephen J Marx
  • Hyperplasia in glands with hormone excess
  • Endocrine-Related Cancer 23 R1–R14 (January 2016)
  • REVIEW: Michael Welsh, Maria Jamalpour, Guangxiang Zang, and Bjorn Akerblom
  • The role of the Src Homology-2 domain containing protein B (SHB) in beta cells
  • Journal of Molecular Endocrinology 56 R21–R31 (January 2016)
  • REVIEW: Ines Cebola and Lorenzo Pasquali
  • Non-coding genome functions in diabetes
  • Journal of Molecular Endocrinology 56 R1–R20 (January 2016)
  • REVIEW: Amy Warner and Jens Mittag
  • Breaking BAT: can browning create a better white?
  • Journal of Endocrinology 227 R19–R29 (January 2016)
  • REVIEW: S S Jonker and S Louey
  • Endocrine and other physiologic modulators of perinatal cardiomyocyte endowment
  • Journal of Endocrinology 227 R1–R18 (January 2016)